These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 8393371

  • 21. Low incidence of microsatellite instability in patients with cervical carcinomas.
    Rodriguez JA, Barros F, Carracedo A, Mugica-van Herckenrode CM.
    Diagn Mol Pathol; 1998 Oct; 7(5):276-82. PubMed ID: 9990486
    [Abstract] [Full Text] [Related]

  • 22. Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer.
    Chen CA, Chen TM, Wu CC, Chang CF, Hsieh CY.
    J Cancer Res Clin Oncol; 1994 Oct; 120(11):678-82. PubMed ID: 7962045
    [Abstract] [Full Text] [Related]

  • 23. p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.
    Busby-Earle RM, Steel CM, Williams AR, Cohen B, Bird CC.
    Br J Cancer; 1994 Apr; 69(4):732-7. PubMed ID: 8142262
    [Abstract] [Full Text] [Related]

  • 24. Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women.
    Das BC, Gopalkrishna V, Das DK, Sharma JK, Singh V, Luthra UK.
    Cancer; 1993 Jul 01; 72(1):147-53. PubMed ID: 8389665
    [Abstract] [Full Text] [Related]

  • 25. Human papillomavirus infection and TP53 gene mutation in primary cervical carcinoma.
    Kim JW, Cho YH, Lee CG, Kim JH, Kim HK, Kim EJ, Han KT, Namkoong SE.
    Acta Oncol; 1997 Jul 01; 36(3):295-300. PubMed ID: 9208900
    [Abstract] [Full Text] [Related]

  • 26. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity.
    Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, Fujinaga K, Notani K, Fukuda H.
    Oncogene; 1996 Apr 18; 12(8):1663-8. PubMed ID: 8622886
    [Abstract] [Full Text] [Related]

  • 27. Occurrence of human papillomavirus types 16 and 18 DNA in cervical carcinomas from Japan: age of patients and histological type of carcinomas.
    Yoshikawa H, Matsukura T, Yamamoto E, Kawana T, Mizuno M, Yoshiike K.
    Jpn J Cancer Res; 1985 Aug 18; 76(8):667-71. PubMed ID: 2995290
    [Abstract] [Full Text] [Related]

  • 28. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
    Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Löning T.
    Int J Cancer; 1995 Nov 27; 63(5):639-45. PubMed ID: 7591279
    [Abstract] [Full Text] [Related]

  • 29. Carcinoma of the vulva: HPV and p53 mutations.
    Lee YY, Wilczynski SP, Chumakov A, Chih D, Koeffler HP.
    Oncogene; 1994 Jun 27; 9(6):1655-9. PubMed ID: 8183560
    [Abstract] [Full Text] [Related]

  • 30. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I, Tanaka H, Shimada Y, Wagata T, Ikenaga M, Imamura M, Ishizaki K.
    Clin Cancer Res; 1995 Jul 27; 1(7):769-73. PubMed ID: 9816044
    [Abstract] [Full Text] [Related]

  • 31. Detection of HPV 16/18 DNA in cervical adenocarcinoma using polymerase chain reaction (PCR) methodology.
    Johnson TL, Kim W, Plieth DA, Sarkar FH.
    Mod Pathol; 1992 Jan 27; 5(1):35-40. PubMed ID: 1311838
    [Abstract] [Full Text] [Related]

  • 32. The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing.
    Kurvinen K, Tervahauta A, Syrjänen S, Chang F, Syrjänen K.
    Anticancer Res; 1994 Jan 27; 14(1A):177-81. PubMed ID: 8166446
    [Abstract] [Full Text] [Related]

  • 33. [The detection of p53 gene and HPV16 oncogene in cervical carcinoma].
    Sun Y, Si L.
    Zhonghua Bing Li Xue Za Zhi; 1995 Feb 27; 24(1):29-32. PubMed ID: 7781112
    [Abstract] [Full Text] [Related]

  • 34. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H.
    Gynecol Oncol; 1997 Apr 27; 65(1):23-9. PubMed ID: 9103386
    [Abstract] [Full Text] [Related]

  • 35. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
    Nakagawa S, Yoshikawa H, Jimbo H, Onda T, Yasugi T, Matsumoto K, Kino N, Kawana K, Kozuka T, Nakagawa K, Aoki M, Taketani Y.
    Br J Cancer; 1999 Mar 27; 79(7-8):1139-44. PubMed ID: 10098748
    [Abstract] [Full Text] [Related]

  • 36. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.
    Tsuda H, Hirohashi S.
    Jpn J Cancer Res; 1992 Nov 27; 83(11):1184-91. PubMed ID: 1336492
    [Abstract] [Full Text] [Related]

  • 37. The relationship between human papillomavirus and p53 gene in conjunctival squamous cell carcinoma.
    Toth J, Karcioglu ZA, Moshfeghi AA, Issa TM, Al-Ma'ani JR, Patel KV.
    Cornea; 2000 Mar 27; 19(2):159-62. PubMed ID: 10746446
    [Abstract] [Full Text] [Related]

  • 38. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A, Nieminen P, Lehtinen M, Paavonen J.
    Cancer; 1996 Jun 01; 77(11):2275-9. PubMed ID: 8635095
    [Abstract] [Full Text] [Related]

  • 39. HPV and p53 in cervical cancer.
    Ngan HY, Stanley M, Liu SS, Ma HK.
    Genitourin Med; 1994 Jun 01; 70(3):167-70. PubMed ID: 8039779
    [Abstract] [Full Text] [Related]

  • 40. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
    Ferguson AW, Svoboda-Newman SM, Frank TS.
    Mod Pathol; 1998 Jan 01; 11(1):11-8. PubMed ID: 9556417
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.